Navigation Links
Phosphagenics' A$19.3 million Capital Raising
Date:7/11/2014

MELBOURNE, Australia, July 11, 2014 /PRNewswire/ -- Australian drug delivery company, Phosphagenics Limited (ASX: POH; OTCQX: PPGNY), today announced that it has raised A$19.3 million via a placement of A$16.3 million to institutional investors in Europe, the U.S., Asia and Australia and A$3 million from a share purchase plan (SPP) to be offered to existing shareholders.  The placement of A$16.3 million will be made in two tranches.

"This capital raising positions us strongly to fulfil our commercialisation objectives and fully funds our scheduled TPM®/opioid clinical trial programs.  The capital raised is earmarked for our pivotal TPM®/Oxymorphone Phase 2 clinical trial in the USA scheduled for the first half of 2015 and our upcoming TPM®/Oxycodone Phase 2 trial in Australia," said CEO, Harry Rosen.

"The capital raising comes at a time when the Company is focusing on exploiting the commercialization of several of its lead programs.  We have recently strengthened our business development capacity in the U.S. to assist in this process.  While we have unquestionably shown that our technology provides enhanced delivery solutions across a wide range of products, we now need to translate this to commercial outcomes," said Harry Rosen.

The completion of this capital raising and the investment by new and existing institutional shareholders is a strong endorsement of the TPM® technology and commercial prospects of Phosphagenics.

The institutional placement is for initially 153,000,000 shares at 8 cents per share. This represents a discount of 11% to the last sale price of 9 cents.  A placement of a further 51,000,000 shares at the same pric
'/>"/>

SOURCE Phosphagenics Limited
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Phosphagenics Appoints Neura Therapeutik as US Strategic Commercial Advisors
2. Immunoprotein Diagnostic Testing Market - Forecasts to 2019: Expected to grow at the highest CAGR of 6% and is expected to be valued at USD 4,943.0 million
3. University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services
4. Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering
5. 2013 Was a Multimillion-Dollar Year for The Trendlines Group
6. Isis Pharmaceuticals to Receive $7.5 Million from Alnylam
7. Sanomedics Secures $5 Million Revolving Credit Facility With TCA Global Credit Master Fund, LP To Fund Growth And Future Acquisitions
8. Forus Health Raises Rs 50 Crore ($8.2 Million) in Series B Funding Led by Asian Healthcare Fund
9. Adamas Pharmaceuticals Earns $40 Million in Milestone Payments from Forest Laboratories for MDX-8704
10. Oxford Finance Closes $25 Million Senior Credit Facility with Entellus Medical
11. Auspex Raises $35 Million And Appoints Industry Veteran Gerald Proehl To Its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... 2015 BioElectronics Corporation (OTC Pink: BIEL), ... Therapy medical devices, announced today that its registry ... trial device has been published in the prominent ... http://www.futuremedicine.com/doi/full/10.2217/PMT.15.35 .  More than 5,000 chronic pain ... assessment.  Chronic pain is a ...
(Date:8/4/2015)... EDISON, N.J. , Aug. 4, 2015 /PRNewswire/ ... biopharmaceutical company focused on the development and commercialization ... Sapirstein , Chief Executive Officer, will present live ... DATE: Thursday, August 6, 2015 TIME: 12:15PM EDT ... will be a live, interactive online event where ...
(Date:8/4/2015)... 4, 2015  Ironshore Pharmaceuticals & Development, Inc. ... a company specializing in personalized medicine, to participate ... designed to evaluate the safety and efficacy of ... Attention-deficit/hyperactivity disorder (ADHD). This is Restore,s second clinical ... originally partnered with Ironshore in 2014 and continues ...
Breaking Medicine Technology:BioElectronics' Landmark 5,000+ Chronic Pain Patient Study Published in Pain Management Medical Journal 2ContraVir to Webcast Investor Presentation on August 6: VirtualInvestorConferences.com 2ContraVir to Webcast Investor Presentation on August 6: VirtualInvestorConferences.com 3Restore Health Secures Another Clinical Trial with Ironshore Pharmaceuticals & Development 2
... voluntary recall of ALL lots of its Ketorolac Tromethamine Injection, USP ... NDC# 0517-0601-25 15 mg/mL ... This recall is in addition to the voluntary recall initiated on ... unexpired lots of Ketorolac Tromethamine Injection, USP, 30 mg/mL ...
... a next-generation oncology diagnostics company focused on improving ... closed a $21 million series A financing. ... and included Bessemer Venture Partners, Physic Ventures and ... ) , On-Q-ity is developing diagnostics to determine ...
Cached Medicine Technology:American Regent Expands Voluntary Recall to Include All Lots of Ketorolac Tromethamine Injection, USP 15 mg/mL; 1mL Single Dose Vials 2Cancer Diagnostics Company, On-Q-ity, Raises $21M in Series A Funding for the Development of Technologies to Personalize Cancer Therapy 2
(Date:8/4/2015)... ... August 04, 2015 , ... An article published July 27th ... a viable method for encouraging people to lose weight. Specifically the study compared control ... weight loss success, adding a financial incentive to the overall incentive of increased health. ...
(Date:8/4/2015)... Santa Barbara, CA (PRWEB) , ... August 04, ... ... if you are suffering from underarm sweat. Evolutions Medical & Day Spa in ... called miraDry, the only non-invasive, FDA cleared treatment that permanently eliminates sweat and ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... of Local Food,” scheduled for Nov. 3 – 4, 2015, at UC San ... sustainably, create new businesses, improve food access, and manage resources efficiently against the ...
(Date:8/4/2015)... ... ... Members receiving care from a doctor who participates in a patient-centered program ... percent lower -- than those members at traditional doctor practices, according to the 2014 ... “The promise of patient-centered, or value-based, care to deliver better quality care at a ...
(Date:8/4/2015)... , ... August 04, 2015 , ... ... checking with “Dr. Google” before calling a physician. In an effort to share ... first health care provider in Pennsylvania to publicly share patient satisfaction ratings and ...
Breaking Medicine News(10 mins):Health News:Article on Incentivizing Weight Loss Mirrors Similar Motivations Surrounding Weight Loss Surgery, Says Dr. Feiz & Associates 2Health News:Simple, Non-Invasive, Permanent Solution To Stop Underarm Sweating in Santa Barbara 2Health News:Simple, Non-Invasive, Permanent Solution To Stop Underarm Sweating in Santa Barbara 3Health News:Diversity of Urban and Hydroponic Farms of the Future to Highlight Seedstock Annual Conference Field Trip 2Health News:Diversity of Urban and Hydroponic Farms of the Future to Highlight Seedstock Annual Conference Field Trip 3Health News:Horizon BCBSNJ: 2014 Results Show Patient-Centered Care Continues to Deliver on Promise of Better Quality Care at a Lower Cost 2Health News:Horizon BCBSNJ: 2014 Results Show Patient-Centered Care Continues to Deliver on Promise of Better Quality Care at a Lower Cost 3Health News:UPMC 1st in Pa. to Share Provider Ratings 2Health News:UPMC 1st in Pa. to Share Provider Ratings 3
... ... its new relationship with La Maestra Community Health Centers of San Diego, California. ONRAD ... for La Maestra and their patients. , ... Riverside, CA (PRWEB) October 8, 2009 -- ONRAD, Inc. ...
... DALLAS Oct. 8, 2009 The antidote for acute ... liver failure due to most other causes if given before ... colleagues at 21 other institutions have found. Acute liver ... in toxins being released into the bloodstream and brain. Patients ...
... ... cancer therapy affect integration into society,• Marriage is predicted by height, physical functioning, cognitive ... Philadelphia ... long-term effects of cancer treatment on physical health, and results of a new study ...
... Calif., Oct. 7 Dr. Richard Merkin, High Desert Medical ... their 19th annual Senior Expo October 1 at the Antelope ... start, ready for free health screenings including screenings for bone ... of course, seasonal flu shots. The theme for this ...
... Center,s Health Care Report Urge Joint Leadership on Health Reform ... statement released by Bipartisan Policy Center Founders and Advisory Board ... , "After 14 months of work, on June 17, 2009, ... the culmination of months of work as advisors to the ...
... As House and Senate leaders negotiate the final details ... warned today that one provision under consideration, the Community Living ... fiscally irresponsible. Moreover, the long-term cost of this new entitlement, ... it appears to produce a short-term windfall. , "The ...
Cached Medicine News:Health News:ONRAD Announces New Partnership with La Maestra Community Health Centers of San Diego, CA 2Health News:Medication effective for acute liver failure in early stages of disease 2Health News:Survivors of Childhood Cancer Less Likely to Marry 2Health News:Survivors of Childhood Cancer Less Likely to Marry 3Health News:Survivors of Childhood Cancer Less Likely to Marry 4Health News:High Desert Medical Group, CEO Dr. Richard Merkin, Host Over 4,000 Seniors at 19th Annual Senior Health Expo, Discuss Savings Using Electronic Medical Records... 2Health News:High Desert Medical Group, CEO Dr. Richard Merkin, Host Over 4,000 Seniors at 19th Annual Senior Health Expo, Discuss Savings Using Electronic Medical Records... 3Health News:High Desert Medical Group, CEO Dr. Richard Merkin, Host Over 4,000 Seniors at 19th Annual Senior Health Expo, Discuss Savings Using Electronic Medical Records... 4Health News:Concord Coalition Warns That New Entitlement Is Not a Valid Health Care Reform Offset 2Health News:Concord Coalition Warns That New Entitlement Is Not a Valid Health Care Reform Offset 3Health News:Concord Coalition Warns That New Entitlement Is Not a Valid Health Care Reform Offset 4
Spacelabs offers an approach that allows your telemetry and step-down units to configure systems to meet their telemetry requirements. Our modular telemetry system data are integrated into the depart...
The Tele-Pro WEP-4200 Telemetry System is an 8-Patient Stand Alone System. Offering capabilities such as arrhythmia analysis, trends and full disclosure, the Tele-Pro is a system to help hospitals to...
ISI Ultra-Light Specialty Table offers the ultimate accessibility for surgeons, technicians and equipment during upper extremity surgeries....
Ademtechs Magnetic Beads are produced by encapsulation of a magnetic oil (patented technology). The magnetic content, uniform particle size, mono-dispersion properties, and the high surface area allo...
Medicine Products: